Cholangiocarcinoma

Showing 1 - 25 of 287

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +7 more
  • CEA-targeted CAR-T cells
  • Wuhu, Anhui, China
    The First Affiliated Hospital of Wannan Medical College
Nov 9, 2023

Predict the Response of Biliary Tract Tumors to Immunotherapy

Recruiting
  • Biliary Tract Tumor
  • Cholangiocarcinoma
  • Blood samples, tumor biopsy specimens will be collected
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 22, 2023

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

EUS-FNA/B Versus ERCP With or Without POCS-TB in Suspected Hilar

Not yet recruiting
  • Klatskin Tumor
  • +3 more
  • The sampling method selected in patients with suspected hilar cholangiocarcinoma
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Aug 14, 2023

Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Cholangiocarcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2023

Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)

Recruiting
  • Pancreatic Cancer
  • Cholangiocarcinoma
  • [68Ga]Ga-FAPI-46 PET/CT
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VUmc
Jul 13, 2023

Cholangiocarcinoma Trial in Worldwide (Tinengotinib 8 mg, Tinengotinib 10 mg, Physician's Choice)

Not yet recruiting
  • Cholangiocarcinoma
  • Tinengotinib 8 mg
  • +2 more
  • Santa Monica, California
  • +13 more
Jul 7, 2023

Hepatobiliary Cancer, Cholangiocarcinoma, Liver Metastases Trial in Tampa (Resistance Training, Aerobic Training)

Recruiting
  • Hepatobiliary Cancer
  • +2 more
  • Resistance Training
  • Aerobic Training
  • Tampa, Florida
    Moffitt Cancer Center
Jun 16, 2023

Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

Recruiting
  • Cholangiocarcinoma
  • Ivosidenib Oral Tablet
  • Düsseldorf, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
May 17, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +7 more
  • WM-A1-3389
  • Pembrolizumab
  • Seoul, Seocho-gu, Korea, Republic of
  • +1 more
May 14, 2023

Cholangiocarcinoma Trial (GNS561 + Trametinib)

Not yet recruiting
  • Cholangiocarcinoma
  • GNS561 + Trametinib
  • (no location specified)
May 22, 2023

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Lymph Node Metastasis Status in Cholangiocarcinoma Patients

Recruiting
  • Cholangiocarcinoma
  • No interventions.
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Feb 1, 2023

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

Recruiting
  • Cholestasis
  • +4 more
  • Biospecimen sampling
  • Aachen, Germany
    RWTH Aachen
Feb 6, 2023

Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)

Recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • Embolization
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Feb 3, 2023

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Durvalumab
  • +5 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)

Active, not recruiting
  • Biliary Tract Neoplasms
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 30, 2023

Patient's Experience in Medical Studies for Cholangiocarcinoma

Not yet recruiting
  • Cholangiocarcinoma
    • (no location specified)
    Jan 26, 2023

    Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

    Recruiting
    • Uterine Cervical Neoplasms
    • +10 more
    • Pembrolizumab/Vibostolimab Co-Formulation
    • +11 more
    • Anchorage, Alaska
    • +65 more
    Jan 27, 2023

    Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide

    Terminated
    • Gastrointestinal Cancer
    • +8 more
    • Serious Illness Conversation Guide (SICG)
    • Quality of Life (QOL) survey
    • Stanford, California
      Stanford Cancer Center
    Jan 25, 2023

    Cholangiocarcinoma Trial (Carrelizumab, Solfantinib)

    Not yet recruiting
    • Cholangiocarcinoma
    • (no location specified)
    Jan 16, 2023

    Multi-Platform Profiling of Resected Biliary Tract Cancer

    Recruiting
    • Biliary Tract Cancer
    • +7 more
    • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
    • Chicago, Illinois
    • +1 more
    Jan 23, 2023